Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Lumos Pharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- 0 vs. Q4 2023
- Shares held
- 2.18M
- −190.9K (−8.1%) vs. Q4 2023
- Total value
- $6.14M
- −$1.38M (−18.4%) vs. Q4 2023
- New holders
- 2
- 8 more added
- Sold out
- 2
- 7 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUMO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 29 | $8.08M |
| Q2 2024 | 36 | $4.82M |
| Q1 2024 | 36 | $6.14M |
| Q4 2023 | 37 | $7.52M |
| Q3 2023 | 34 | $8.05M |
| Q2 2023 | 35 | $7.90M |
| Q1 2023 | 37 | $7.40M |
| Q4 2022 | 38 | $8.51M |
| Q3 2022 | 35 | $23.0M |
| Q2 2022 | 36 | $18.7M |
| Q1 2022 | 36 | $23.3M |
| Q4 2021 | 38 | $18.7M |
| Q3 2021 | 37 | $27.3M |
| Q2 2021 | 40 | $32.1M |
| Q1 2021 | 41 | $38.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Lumos Pharma, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 78 | $0 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 3 | $8 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 11 | $31 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 41 | $116 | 0.00% | +3+7.9% | Added |
| Group One Trading, L.P. | 150 | $423 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 154 | $435 | 0.00% | −4,456−96.7% | Reduced |
| Morgan Stanley | 166 | $468 | 0.00% | 00.0% | Unchanged |
| West Financial Advisors, LLC | 784 | $2.21K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,800 | $5.08K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,691 | $7.59K | 0.00% | +1,117+71.0% | Added |
| UBS Group AG | 3,733 | $10.5K | 0.00% | +3,659+4,944.6% | Added |
| Paladin Advisory Group, LLC | 4,387 | $12.5K | 0.01% | 00.0% | Unchanged |
| Key Financial Inc | 10,927 | $30.8K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 11,237 | $31.7K | 0.00% | 00.0% | Unchanged |
| Wealth Advisors of Iowa, LLC | 11,699 | $33.0K | 0.02% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,858 | $33.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 13,286 | $37.5K | 0.00% | +13,286 | New |
| Private Advisor Group, LLC | 16,013 | $45.2K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 16,115 | $45.4K | 0.00% | +4,173+34.9% | Added |
| Marquette Asset Management, LLC | 25,760 | $72.6K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 27,643 | $78.0K | 0.00% | −20,000−42.0% | Reduced |
| Dimensional Fund Advisors LP | 29,617 | $83.5K | 0.00% | +14,053+90.3% | Added |
| Two Sigma Advisers, LP | 31,900 | $90.0K | 0.00% | +3,600+12.7% | Added |
| Millennium Management LLC | 37,579 | $106.0K | 0.00% | +37,579 | New |
| Two Sigma Investments, LP | 38,817 | $109.5K | 0.00% | −3,802−8.9% | Reduced |
| BlackRock Inc. | 41,104 | $115.9K | 0.00% | −2,356−5.4% | Reduced |
| Geode Capital Management, LLC | 47,596 | $134.2K | 0.00% | 00.0% | Unchanged |
| Greenwich Wealth Management LLC | 76,341 | $215.0K | 0.02% | 00.0% | Unchanged |
| Blackstone Group Inc. | 78,624 | $221.7K | 0.00% | −247,928−75.9% | Reduced |
| Lion Point Capital, LP | 90,794 | $256.0K | 0.49% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 120,651 | $340.2K | 0.01% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 140,689 | $396.7K | 0.20% | +15,407+12.3% | Added |
| Renaissance Technologies LLC | 218,014 | $615.0K | 0.00% | −3,600−1.6% | Reduced |
| Vanguard Group Inc | 244,082 | $688.3K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 406,612 | $1.15M | 0.00% | +10.0% | Added |
| Wells Fargo & Company | 415,551 | $1.17M | 0.00% | −1,500−0.4% | Reduced |
| Cypress Capital Management LLC (WY) | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Live Oak Investment Partners | – | – | – | – | Not filed |